Mutations in modifiers such as isocitrate dehydrogenase 1/2 (IDH1/2) and telomerase reverse transcriptase (TERT) lead to global changes in the epigenome, being common companions of glioma pathogenesis [2,3]. This evidence concerns the gene TERT and central nervous system cancer.